Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (400)	1/5/1999 11:24:00 PM
From: Zvi Steinberg	Read Replies (2) \| Respond to of 1386

Interesting....... MKs mull medical marijuana By Anat Cygielman, Ha'aretz Correspondent The Knesset subcommittee on drugs, chaired by MK Naomi Chazan (Meretz), yesterday discussed the possibility of legalizing the use of raw cannabis (marijuana and hashish) for medical purposes. The subcommittee recommended the creation of an expert committee that would consider requests for such use; each case would be decided on its own merits. Prescriptions for synthetic drugs, based on the active material in cannabis, have been issued for years in the symptomatic treatment of persons suffering from AIDS, cancer and asthma. The drug's active ingredient, tetrahydrocannabinol (THC), was isolated and developed in Israel in the 1960's by Professors Raphael Meshulam and Yehiel Geoni of the Hebrew University of Jerusalem. Physicians use the synthetic drugs primarily to relieve pain, to reduce nausea produced by chemotherapy and to increase the appetite of AIDS patients. Criticism was voiced at the subcommittee meeting over the fact that the health ministry has not yet acted upon the recommendations of a committee headed by Prof. Meshulam in 1995, which proposed the creation of an experts committee that would allow the medical use of cannabis in special cases. www3.haaretz.co.il